AlzeCure Pharma AlzeCure Pharma AB, a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer’s disease and pain, announced that the Japenese Patent Office has granted a patent covering the company’s leading candidate drug ACD856, from the NeuroRestore platform, which is developed against Alzheimer’s disease and other disorders with cognitive impairment.
